Mayne Pharma Investor Relations Material

Mayne Pharma Group Limited is an Australian pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic pharmaceutical products. The company’s portfolio spans various therapeutic areas, including women’s health, dermatology, and pain management, with products available in oral, topical, and injectable forms. Mayne Pharma operates manufacturing facilities in Australia and the United States, and its services include contract development and manufacturing for other pharmaceutical companies. The company is headquartered in Salisbury, South Australia, and its shares are listed on the Australian Securities Exchange.